top of page
Healthtech Innovations from Sahlgrenska Chosen for TECHARENA Top 46
Two companies from Sahlgrenska Science Park’s CO-AX portfolio, BrainLink Health and TrialMe, have been selected among the Top 46 startups at TECHARENA 2026.
“We are incredibly proud to see companies from our incubator recognized on the TECHARENA. It’s a clear testament to the ambition of these teams — and to the power of an ecosystem where startups, world-class research, and industry partners come together to turn breakthrough health innovations into global impact,” says Cecilia Edebo, CEO of Sahlgrenska Science Park
On February 11, they will take the stage to pitch their solutions to an international audience of investors, partners and industry leaders.
TECHARENA brings together leading startups, investors and industry representatives. The selection highlights the strong innovation emerging at the intersection of health, technology and research.
BrainLink Health and TrialMe are developing solutions that address global health challenges. Their participation at TECHARENA marks an important milestone in their continued growth journeys.
Photo credits: TECHARENA
bottom of page